Quantum-Si (NASDAQ:QSI – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. They currently have a $4.00 price target on the stock. HC Wainwright’s target price would indicate a potential upside of 309.42% from the company’s previous close.
A number of other research analysts have also recently weighed in on the company. Wall Street Zen upgraded Quantum-Si from a “sell” rating to a “hold” rating in a research report on Saturday, September 12th. Alliance Global Partners reaffirmed a “buy” rating on shares of Quantum-Si in a research note on Friday, August 14th. Finally, Weiss Ratings raised Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Quantum-Si has an average rating of “Hold” and an average target price of $2.50.
Read Our Latest Analysis on QSI
Quantum-Si Trading Up 22.9%
Quantum-Si (NASDAQ:QSI – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11). Quantum-Si had a negative return on equity of 47.12% and a negative net margin of 6,138.26%.The business had revenue of $0.34 million during the quarter, compared to analysts’ expectations of $0.30 million. Research analysts anticipate that Quantum-Si will post -0.47 EPS for the current year.
Institutional Trading of Quantum-Si
Hedge funds have recently added to or reduced their stakes in the business. Renaissance Technologies LLC acquired a new stake in Quantum-Si in the 1st quarter worth about $91,000. WINTON GROUP Ltd acquired a new stake in Quantum-Si in the 2nd quarter worth about $67,000. Green Alpha Advisors LLC acquired a new stake in Quantum-Si in the 2nd quarter worth about $41,000. Corient Private Wealth LP acquired a new stake in Quantum-Si in the 2nd quarter worth about $34,000. Finally, Hollencrest Capital Management increased its holdings in shares of Quantum-Si by 301.1% during the 1st quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock worth $31,000 after buying an additional 30,111 shares during the last quarter. 39.90% of the stock is owned by institutional investors and hedge funds.
About Quantum-Si
Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.
Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.
Recommended Stories
- Five stocks we like better than Quantum-Si
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
- Tesla’s Semi Is Finally Here—But Will It Move the Stock?
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
